Published in

Cambridge University Press, British Journal of Psychiatry, 2(195), p. 170-177, 2009

DOI: 10.1192/bjp.bp.108.057380

Links

Tools

Export citation

Search in Google Scholar

Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

BackgroundThe UK National Institute for Health and Clinical Excellence (NICE) has recommended that cost-effectiveness analysis includes the EQ–5D; however, this is often not implemented in the area of mental health.AimsTo assess the appropriateness of using the EQ–5D to measure improvements in mental health.MethodSeventy-seven participants with psychosis were rated according to the EQ–5D and seven measures of mental health at both pre- and post-intervention. To assess construct validity we compared the (pre-intervention) mean EQ–5D scores for those with milder and more severe scores, according to each of the seven measures. To assess responsiveness we estimated the mean EQ–5D change score for those who improved (post-intervention), according to each of the measures.ResultsThe mean EQ–5D score was more favourable for both those with milder scores (mean difference: 0.044 to 0.301) and for those who improved post-intervention (mean change: 0.029 to 0.117).ConclusionsThis suggests the EQ–5D should be considered for use in future cost-effectiveness studies in the area of mental health.